Laser energy produces changes in oxidation/reduction status of the mitochondria which lead to dramatic increases in ATP synthesis. Activation of the sodium/potassium pump alters the cell membrane permeability to calcium. Laser therapy has been shown to effect cellular activity in the following ways: stimulate cell growth, increase cell metabolism, improve cell regeneration, produce an anti-inflammatory response, produce an edema reduction, reduce fibrous tissue formation, stimulate nerve function, reduce the production of Substance P, and stimulate long-term production of nitric oxide.

The patented MLS M8 Robotic Laser was developed as a result of nearly three decades of scientific research that studied the biological and therapeutic effects of different emission components and methods. The Departments of Biology at both the University of Turin (Italy) and the University of Padova (Brazil), as well as the Department of Anatomy and the Orthopedic Clinic at the University of Padova, have studied and verified the unique effectiveness of MLS M8 Robotic Laser Therapy. There have been more than 2,500 published studies worldwide involving low-level laser therapy, with approximately 120 double-blind studies publi

The MLS M8 Robotic Therapy Laser is free from any known side effects and has few contraindications. It is, therefore, safe to use for the majority of patients suffering from acute and chronic orthopedic conditions, as well as patients seeking to recover from surgery more quickly. Acute patients typically require 6 treatments over 2-3 weeks. Chronic patients are usually treated 7-10 times over 3-4 weeks. Treatment times range from 4-10 minutes, depending on the condition being treated.

Regulations vary by state and should be closely examined by potential franchisees, however, the majority of states require only a properly trained medical assistant to operate the laser.